Walisbeth Class-Vazquez
Gastroenterology · Caguas, PRNPI 1518302652
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.5%), food and beverage and education — rather than concentrated in one kind of arrangement. AbbVie accounts for 77.5% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $2,545 and has fallen 80.8% since, to $490 in 2025.
Across 78 payments — averaging $56.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$239
- Takeda Pharmaceuticals U.S.A., Inc.$185
- Madrigal Pharmaceuticals$169
- E.r. Squibb & Sons, L.L.C.$124
- Amneal Pharmaceuticals LLC$120
- plus $147 from 7 others
What the payments were for
- Consulting fees$2,25051%
- Travel & lodging$281%
- Food & beverage$2,00146%
- Education$932%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 42 | $3,387 |
| Johnson & Johnson(2 entities) | 9 | $239 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $185 |
| Madrigal Pharmaceuticals | 2 | $169 |
| E.r. Squibb & Sons, L.L.C. | 6 | $124 |
| Amneal Pharmaceuticals LLC | 1 | $120 |
| Daiichi Sankyo Inc. | 2 | $32 |
| UCB, Inc. | 2 | $29 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
| Alfasigma USA, Inc. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Vivus LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,372 in reported general payments places this provider in the 75th percentile of 198 gastroenterology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SuprepSodium, Potassium,mag Sulfates | 65 | $7,593 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 44 | $7,346 |
| Dexlansoprazole DrDexlansoprazole | 25 | $5,956 |
| Mesalamine | 22 | $3,426 |
| Omeprazole | 420 | $2,764 |
| Sucralfate | 35 | $2,758 |
| Famotidine | 180 | $1,633 |
| Pantoprazole Sodium | 151 | $1,393 |
| CholestyramineCholestyramine (With Sugar) | 17 | $1,268 |
| Dicyclomine Hcl | 48 | $1,077 |
| Clarithromycin | 18 | $738 |
| Hydrocortisone | 22 | $339 |
| Midazolam Hcl | 125 | $324 |
| Amoxicillin | 23 | $316 |
| Fentanyl CitrateFentanyl Citrate/Pf | 82 | $284 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Caguas
- Miguel de Varona-NegronCaguas$68K
- Gines Martinez MangualCaguas$10K
- Emanuel Warrington ColonCaguas$4K
- Ahmed Morales JorgeCoto Laurel$214K
- Barbara Rosado CarrionPonce$176K
- Rafael Pastrana LabordeHato Rey$76K
- Marcia Cruz CorreaSan Juan$62K
- Francisco CebolleroMayaguez$52K
- Loscar SantiagoSan Juan$39K
- Henry Gonzalez RiveraSan Juan$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.